Novartis Wants Lupin's Generic Heart Failure Drug Blocked
Novartis has again accused Lupin of infringing patents covering the chronic heart failure drug Entresto by requesting U.S. Food and Drug Administration approval for a generic version of the blockbuster medication....To view the full article, register now.
Already a subscriber? Click here to view full article